{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase
- PMID: 15878855
- DOI: 10.1074/jbc.M501129200
{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase
Abstract
The insulin-like growth factor-1 receptor (IGF-1R) plays important roles in physiological growth and aging as well as promoting several crucial functions in cancer cells. However, the molecular mechanisms involved in expression and down-regulation of IGF-1R are still poorly understood. Here we provide evidence that beta-arrestin, otherwise known to be involved in the regulation of G protein-coupled receptors, serves as an adaptor to bring the oncoprotein E3 ubiquitin ligase MDM2 to the IGF-1R. In this way, beta-arrestin acts as a crucial component in the ubiquitination and down-regulation of the receptor. Both MDM2 and beta-arrestin co-immunoprecipitated with the IGF-1R. The beta-arrestin isoform 1 appeared to be more strongly associated with the receptor than isoform 2, and in a molecular context it was 4-fold more efficient in inducing polyubiquitination of IGF-1R, a reaction that required the presence of beta-arrestin and MDM2. Ligand stimulation accelerated IGF-1R ubiquitination. In mouse P6 cells (overexpressing human IGF-1R) absence of beta-arrestin 1, but not of beta-arrestin 2, blocked ubiquitination of IGF-1R. Conversely, in the two studied human melanoma cell lines both beta-arrestin isoforms seemed to be involved in IGF-1R ubiquitination. However, because depletion of beta-arrestin 1 almost completely eliminated degradation, and IGF-1 induced down-regulation of the receptor in these cells, whereas beta-arrestin 2 only had a partial effect, beta-arrestin 1 seems to the more important isoform in affecting the expression of IGF-1R. To our knowledge this is the first study demonstrating a defined molecular role of beta-arrestin with direct relevance to cell growth and cancer.
Similar articles
-
beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.Mol Cell Biol. 2004 Oct;24(20):8929-37. doi: 10.1128/MCB.24.20.8929-8937.2004. Mol Cell Biol. 2004. PMID: 15456867 Free PMC article.
-
Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1.Oncogene. 2008 Mar 6;27(11):1629-38. doi: 10.1038/sj.onc.1210797. Epub 2007 Sep 10. Oncogene. 2008. PMID: 17828296
-
Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor.Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8247-52. doi: 10.1073/pnas.1431613100. Epub 2003 Jun 23. Proc Natl Acad Sci U S A. 2003. PMID: 12821780 Free PMC article.
-
Beta-arrestin and Mdm2, unsuspected partners in signaling from the cell surface.Sci STKE. 2001 Nov 27;2001(110):pe41. doi: 10.1126/stke.2001.110.pe41. Sci STKE. 2001. PMID: 11724970 Review.
-
Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation.Cell Mol Life Sci. 2014 Jul;71(13):2403-27. doi: 10.1007/s00018-013-1514-y. Epub 2013 Nov 26. Cell Mol Life Sci. 2014. PMID: 24276851 Free PMC article. Review.
Cited by
-
Arrestins: A Small Family of Multi-Functional Proteins.Int J Mol Sci. 2024 Jun 6;25(11):6284. doi: 10.3390/ijms25116284. Int J Mol Sci. 2024. PMID: 38892473 Free PMC article. Review.
-
β-arrestin1 is an E3 ubiquitin ligase adaptor for substrate linear polyubiquitination.J Biol Chem. 2023 Dec;299(12):105474. doi: 10.1016/j.jbc.2023.105474. Epub 2023 Nov 21. J Biol Chem. 2023. PMID: 37981209 Free PMC article.
-
GPCR targeting of E3 ubiquitin ligase MDM2 by inactive β-arrestin.Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2301934120. doi: 10.1073/pnas.2301934120. Epub 2023 Jul 3. Proc Natl Acad Sci U S A. 2023. PMID: 37399373 Free PMC article.
-
Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?Cell Mol Biol Lett. 2021 Dec 15;26(1):53. doi: 10.1186/s11658-021-00293-6. Cell Mol Biol Lett. 2021. PMID: 34911439 Free PMC article. Review.
-
IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma.Oncogene. 2022 Jan;41(4):600-611. doi: 10.1038/s41388-021-02111-x. Epub 2021 Nov 17. Oncogene. 2022. PMID: 34785779
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous